Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
EC/CAS
236-675-5
Name of the chemical
Titandioxid; [in Pulverform mit mindestens 1 % Partikel mit aerodynamischem Durchmesser ≤ 10 μm] (2020/217)
Concentration
N/A
General Information
Revision date
2019-07-12
Product name
PLACEBO GEPOTIDACIN TABLETS 750 MG
Product Synonyms
GEPOTIDACIN PLACEBO, FORMULATED PRODUCT
1.2.1 Relevant identified uses
Investigational Medicinal Product
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Section 2
EU Classification
Regulation (EC) No 1272/2008 as amended Hazard summary Caution - Pharmaceutical agent. Direct contact with eyes may cause temporary irritation. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, Titanium dioxide
Hazard pictograms
None.
Signal word
None.
Hazard statements
The mixture does not meet the criteria for classification.
Prevention
Not available.
Response
Not available.
Storage
Not available.
Disposal
Not available.
Supplemental label elements
96.89 % of the mixture consists of component(s) of unknown acute oral toxicity. 98.84 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 98.84 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
